field
hostguest
chemistri
wide
use
host
probabl
cyclodextrin
cd
cd
abl
increas
water
solubl
numer
drug
inclus
hydrophob
caviti
widespread
use
develop
numer
pharmaceut
formul
nevertheless
cd
also
abl
interact
endogen
substanc
origin
organ
tissu
cell
interact
use
vast
array
topic
includ
cholesterol
manipul
treatment
alzheim
diseas
control
pathogen
etc
addit
use
natur
cd
offer
great
advantag
avoid
reduc
use
common
petroleumsourc
drug
paper
gener
featur
applic
cd
review
well
interact
isol
biomolecul
lead
format
inclus
exclus
complex
final
potenti
medic
applic
highlight
throughout
sever
exampl
cyclodextrin
cd
discov
identifi
centuri
ago
pringsheim
cowork
demonstr
abil
cd
form
complex
mani
organ
molecul
sinc
structur
elucid
three
natur
cd
compos
link
glycosid
bond
allow
develop
ration
studi
encapsul
properti
water
solubl
differ
significantli
great
varieti
modifi
cd
develop
improv
stabil
solubl
inclus
complex
nowaday
cd
wide
appli
mani
field
due
hostguest
properti
origin
produc
starch
enzymat
convers
rel
low
price
easi
modif
biodegrad
low
toxic
moreov
cd
abl
interact
wide
rang
biomolschem
structur
convent
represent
nativ
cd
ecul
open
way
mani
biolog
applic
major
research
base
abil
cd
extract
lipid
cell
membran
object
contribut
focu
potenti
use
natur
chemic
modifi
cd
vast
array
medic
biolog
applic
cyclodextrin
synthesi
structur
physicochem
properti
mention
earlier
ordinari
starch
hydrolysi
eg
corn
starch
enzym
ie
cyclodextrin
glycosyl
transferas
cgtase
allow
product
nativ
cd
reduc
separ
purif
cost
select
develop
last
two
decad
nevertheless
cheapest
remain
wherea
expens
molecular
shape
nativ
cd
repres
truncat
cone
hydrophob
caviti
accommod
hydrophob
compound
scheme
aqueou
solut
complex
enthalp
entrop
driven
addit
complementari
interact
eg
van
der
waal
forc
hbond
etc
appear
cd
guest
nonpolar
suitablys
guest
may
bound
numer
molar
ratio
eg
etc
case
knowledg
bind
constant
k
ass
crucial
valu
provid
index
hostguest
bind
forc
cd
also
form
exclus
complex
cd
bound
guest
hbond
network
instanc
complex
pmo
anion
result
onedimension
columnar
structur
combin
intermolecular
interact
unfortun
natur
cd
well
inclus
complex
limit
aqueou
solubl
lead
precipit
fortun
nativ
cd
effect
templat
gener
wide
rang
molecular
host
chemic
modif
order
meet
specif
requir
hostguest
complex
chemic
modif
make
possibl
tailor
cd
particular
guest
hydroxi
group
serv
scaffold
substitu
easili
introduc
chemic
synthesi
point
view
reactiv
differ
primari
secondari
hydroxi
group
allow
select
function
narrow
wider
edg
truncat
cone
tabl
access
gamut
function
group
greatli
expand
util
nativ
modifi
cd
numer
applic
natur
cd
deriv
abl
encapsul
wide
rang
guest
molecul
caviti
use
wide
rang
applic
includ
analyt
chemistri
agricultur
food
technolog
catalysi
cosmet
textil
process
environment
protect
technolog
nevertheless
first
global
consum
cd
clearli
pharmaceut
industri
inde
cd
use
form
inclus
complex
wide
rang
drug
becom
valuabl
tool
formul
order
overcom
deliveri
limit
result
numer
formul
use
cd
market
worldwid
tabl
iv
toxic
biolog
effect
nativ
modifi
cyclodextrin
safeti
toxic
import
criteria
consider
use
cd
pharmaceut
product
section
deal
toxicolog
issu
nativ
unlik
hydrolyz
pancreat
amylas
human
salivari
ferment
intestin
microflora
administ
oral
nativ
cd
hydrophil
deriv
absorb
human
gastrointestin
tract
thu
make
practic
nontox
due
high
molecular
mass
rang
almost
gmol
hydrophil
natur
signific
number
hbond
donor
acceptor
inde
cd
violat
three
criteria
lipinski
rule
hbond
donor
ii
hbond
acceptor
iii
molecular
mass
less
gmol
iv
octanolwat
partit
coeffici
log
p
greater
criteria
appli
absorpt
passiv
diffus
compound
cell
membran
absorpt
nativ
cd
hydrophil
deriv
allow
intact
form
cellular
absorpt
occur
passiv
transport
cytoplasm
membran
ie
transport
protein
contrast
lipophil
deriv
eg
interact
readili
membran
hydrophil
deriv
readili
permeat
cell
membran
see
moreov
oral
administr
alkyl
cd
deriv
limit
potenti
toxic
inde
partial
absorb
gastrointestin
tract
system
circul
moreov
shown
toxic
parenter
administr
opposit
hold
hydrophil
cd
deriv
consid
safe
parenter
administr
gener
way
appear
global
safer
alkyl
cd
less
suitabl
parent
administr
tabl
present
pharmacokinet
safeti
overview
natur
modifi
cd
administ
natur
hydrophil
cd
deriv
disappear
rapidli
system
circul
distribut
variou
tissu
bodi
kidney
liver
urinari
bladder
etc
nevertheless
mainli
renal
excret
intact
high
concentr
taken
b
randomli
methyl
alkyl
cd
present
renal
damag
dysfunct
stella
discuss
detail
studi
toxicolog
mutagen
teratogen
carcinogen
variou
cd
overt
sign
acut
toxic
appar
cd
ie
inflammatori
respons
cell
degener
also
genotox
teratogen
mutagen
howev
cd
affect
human
organ
extrem
high
concentr
nevertheless
princip
side
effect
natur
modifi
cd
probabl
cell
toxic
effect
directli
correl
hemolyt
activ
inde
sever
vitro
studi
report
erythrocyt
lysi
although
toxicolog
implic
vivo
neglig
lysi
mechan
relat
capac
draw
phospholipid
cholesterol
biolog
membran
see
base
complex
endogen
substanc
potenti
interest
mani
applic
nativ
modifi
cd
use
complex
certain
chemic
produc
natur
present
cell
tissu
ie
endogen
substanc
inde
cd
abl
form
complex
variou
biomolecul
includ
lipid
carbohydr
protein
nucleic
acid
section
biomoleculecd
inclus
complex
present
lipid
hydrophob
amphiphil
molecul
divers
includ
among
fat
wax
sterol
fatsolubl
vitamin
phospholipid
mono
diand
triglycerid
etc
amphiphil
natur
caus
molecul
certain
lipid
organ
liposom
aqueou
medium
properti
allow
format
biolog
membran
inde
cell
organel
membran
compos
lipid
lipid
also
provid
variou
biolog
function
includ
cell
signal
storag
metabol
energi
lipogenesi
biolog
lipid
basic
due
two
type
compound
act
build
block
ketoacyl
group
isopren
unit
point
view
divid
eight
categori
fatti
acid
deriv
mono
diand
triglycerid
phospholipid
acylglycerol
phosphoglycerid
sphingolipid
glycolipid
polyketid
result
condens
ketoacyl
group
sterol
eg
cholesterol
prenol
produc
condens
isopren
unit
compound
easili
includ
insid
cd
hydrophob
amphiphil
molecul
mention
earlier
becom
exceed
clear
throughout
follow
section
major
research
involv
cd
revolv
around
abil
manipul
lipid
phospholipid
cholesterol
composit
differ
cell
although
numer
studi
deal
topic
mechan
process
poorli
investig
ie
consequ
phenomenon
report
sake
clariti
typic
exampl
report
section
first
welldocu
effect
cd
probabl
hemolysi
correspond
lysi
red
blood
cell
erythrocyt
releas
content
surround
fluid
blood
plasma
iri
cowork
report
nativ
cd
abl
caus
hemolysi
human
erythrocyt
behavior
occur
rel
high
concentr
mm
degre
cholesterol
extract
function
cd
use
concentr
incub
time
temperatur
instanc
given
condit
isoton
solut
similar
incub
time
temperatur
observ
hemolysi
order
differ
effect
observ
nativ
cd
explain
ohtani
et
al
membran
erythrocyt
compos
protein
associ
lipid
carbohydr
fraction
cholesterol
total
membran
lipid
propos
explan
base
specif
interact
natur
cd
erythrocyt
membran
compon
inde
excel
suit
solubil
phospholipid
cholesterol
respect
wherea
gener
less
lipidselect
detail
cd
affin
solubil
variou
lipid
compon
erythrocyt
membran
order
phospholipid
cholesterol
find
corrobor
work
leventi
silviu
report
acceler
rate
cholesterol
transfer
larger
factor
acceler
transfer
phospholipid
wherea
opposit
true
hemolyt
properti
cd
gener
behavior
limit
human
erythrocyt
mammalian
red
blood
cell
affect
parent
cd
instanc
dog
erythrocyt
also
affect
nativ
cd
order
thu
magnitud
hemolyt
activ
observ
dog
erythrocyt
consist
order
magnitud
human
erythrocyt
see
discuss
howev
hemolyt
activ
larg
influenc
substitu
attach
cd
presenc
hydrophil
substitu
eg
glucosyl
maltosyl
sulfat
sulfobutyl
ether
etc
reduc
hemolyt
activ
comparison
parent
cd
lipophil
one
eg
methyl
cd
demonstr
strongest
hemolyt
activ
parent
cd
differ
ascrib
differ
solubil
effect
lipid
compon
sequestr
extern
aqueou
phase
hemolysi
attribut
remov
erythrocyt
membran
compon
particularli
phospholipid
cholesterol
valu
bind
constant
cd
lipid
relev
author
knowledg
one
paper
literatur
describ
bind
constant
cd
short
phospholipid
ie
diheptanoylphosphatidylcholin
dhpc
studi
associ
constant
estim
h
nmr
measur
result
prove
k
valu
order
k
valu
order
behavior
attribut
larg
caviti
abl
incorpor
alkyl
chain
dhpc
simultan
contrast
format
inclus
complex
easier
find
corrobor
fauvel
cowork
report
strongest
affin
phospholipid
eg
phosphatidylinositol
nishijo
et
al
studi
interact
variou
cd
dipalmitoyl
distearoyl
dimyristoylphosphatidylcholin
liposom
studi
highlight
liposomecd
interact
depend
length
fatti
acid
chain
phospholipid
caviti
size
natur
substitu
cd
literatur
bind
constant
cholesterol
estim
around
solubl
method
valu
prove
good
stabil
inclus
complex
drive
forc
complex
hydrophob
interact
despit
inform
bind
constant
observ
inclus
cholesterol
caviti
intern
diamet
deriv
perfectli
match
size
sterol
molecul
contrari
larg
moreov
posit
correl
observ
hemolyt
activ
variou
modifi
cd
abil
solubil
cholesterol
reveal
shown
effici
cholesterolacceptor
molecul
appar
due
diamet
intern
caviti
match
size
molecul
final
noteworthi
cd
lose
abil
induc
hemolysi
caviti
occupi
guest
molecul
due
reduc
interact
erythrocyt
membran
observ
support
aforement
affin
phospholipid
cholesterol
addit
subhemolyt
concentr
nativ
cd
also
demonstr
caus
shape
chang
human
erythrocyt
hemolyt
effect
concomit
shape
chang
biconcav
discocyt
stomatocyt
echinocyt
depend
caviti
size
cd
instanc
induc
progress
shape
chang
discocyt
stomatocyt
stomatocyt
spherocyt
contrast
lead
swell
erythrocyt
similar
effect
found
chemic
modifi
cd
final
noteworthi
presenc
also
lead
hemolysi
cholesterol
interact
markedli
higher
affin
sphingolipid
eg
sphingomyelin
scheme
propos
mechan
morpholog
chang
erythrocyt
induc
methyl
cd
common
membran
phospholipid
extract
cholesterol
sphingomyelin
lead
strong
modif
cholesterolrich
sphingomyelinrich
lipid
raft
respect
therefor
even
target
significantli
differ
final
effect
ie
hemolysi
note
cholesterol
andor
phospholipid
extract
limit
erythrocyt
inde
eukaryot
prokaryot
cell
affect
presenc
cd
instanc
cytotox
nativ
methyl
hydroxypropyl
studi
vitro
model
bloodbrain
barrier
monnaert
cowork
result
prove
nativ
cd
toxic
expect
lipid
efflux
brain
capillari
endotheli
cell
presenc
nativ
cd
reveal
extract
phospholipid
wherea
abl
remov
phospholipid
cholesterol
contrast
less
lipidselect
nativ
cd
differenti
effect
compar
order
magnitud
hemolyt
activ
could
ascrib
lower
cholesterol
content
bloodbrain
barrier
cell
compar
erythrocyt
inde
cholesterol
fraction
markedli
higher
erythrocyt
cell
hemolysi
presenc
hydrophil
substitu
eg
sulfobutyl
ether
annihil
cytotox
presenc
methyl
residu
induc
cell
death
variou
cell
etc
instanc
cell
death
induc
caus
mark
apoptosi
mechan
ie
process
cell
trigger
selfdestruct
respons
signal
lead
cell
chang
prior
death
jurkat
cell
apoptosi
process
result
cholesterol
extract
lead
inhibit
activ
pathway
presenc
repercuss
total
opposit
inde
cell
death
result
nonapoptot
mechan
ie
necrosi
differenti
effect
could
attribut
dissimilar
interact
methyl
cd
cholesterolrich
lipid
raft
sphingomyelinrich
domain
respect
result
suggest
lipid
raft
cell
membran
would
involv
cell
death
cellular
function
howev
mechan
cholesterol
extract
mediat
cd
still
open
discuss
instanc
yancey
et
al
propos
cd
diffus
proxim
erythrocyt
membran
lead
lipid
complex
without
complet
desorpt
aqueou
phase
contrast
besenicar
et
al
propos
cd
complex
lipid
natur
exchang
membran
aqueou
phase
stella
suppos
cd
interact
directli
membran
cell
prior
lipid
efflux
idea
mascetti
et
al
propos
cd
interact
directli
cholesterol
base
molecular
simul
et
al
propos
follow
mechan
associ
cd
aqueou
solut
form
dimer
ii
bind
dimer
membran
surfac
iii
extract
complex
cholesterol
iv
desorpt
cdcholesterol
aqueou
solut
howev
whatev
molecular
mechan
lipid
efflux
mediat
cd
clearli
differ
surfact
inde
low
concentr
mechan
involv
penetr
deterg
molecul
lipid
membran
lead
increas
fluiditi
contrast
higher
concentr
extract
membran
constitu
ensur
micellar
solubil
protein
polym
amino
acid
coval
link
peptid
bond
natur
protein
determin
primarili
amino
acid
sequenc
constitut
primari
structur
amino
acid
differ
chemic
properti
arrang
along
polypeptid
chain
determin
spatial
arrang
describ
local
secondari
tertiari
structur
secondari
structur
describ
arrang
amino
acid
residu
observ
atom
scale
stabil
mainli
hbond
eg
turn
tertiari
structur
correspond
gener
shape
observ
protein
across
whole
molecul
describ
interact
differ
element
secondari
structur
final
assembl
sever
protein
subunit
form
function
complex
describ
quaternari
structur
amino
acid
hydrophob
side
chain
eg
alanin
valin
leucin
isoleucin
prolin
phenylalanin
tryptophan
cystein
methionin
easili
includ
insid
cd
complex
lead
modif
protein
sake
clariti
typic
exampl
report
section
paper
differenti
effect
nativ
cd
ohtani
cowork
highlight
addit
extract
lipid
cd
also
abl
solubil
protein
order
sharma
jani
studi
interact
cd
hydrophob
protein
lead
format
solubl
insolubl
complex
cd
caus
precipit
lipoprotein
order
behavior
could
ascrib
format
inclus
complex
howev
present
data
exclud
format
exclus
complex
sever
year
later
pitha
report
studi
interact
cd
peptid
contain
aromat
amino
acid
competit
spectrophotometri
measur
pnitrophenol
compet
reagent
ph
author
determin
stabil
constant
aromat
amino
acid
oligopeptid
estim
constant
free
lphenylalanin
phe
increas
order
moreov
result
prove
stabil
oligopeptid
contain
phe
higher
phe
instanc
bind
constant
free
phe
estim
wherea
glyglyph
tripeptid
bind
constant
nevertheless
complex
occur
nativ
function
form
protein
unfold
beko
et
al
investig
role
ltyrosin
tyr
residu
bind
pentapeptid
two
peptid
use
studi
tyrileglyserarg
yigsr
tyrglyglypheleu
yggfl
former
interact
specif
integrin
receptor
specif
neuron
cell
wherea
latter
known
bind
brain
receptor
site
steadyst
fluoresc
spectroscopi
estim
constant
free
tyr
increas
order
previou
studi
stabil
constant
pentapeptid
contain
tyr
higher
tyr
free
tri
yigsr
yggfl
respect
therefor
pentapeptid
conform
affect
stabil
inclus
complex
contrast
inclus
complex
affect
oligopeptid
conform
free
tri
yigsr
yggfl
respect
year
lovatt
cowork
investig
dissoci
bovin
insulin
oligom
induc
aqueou
solut
energet
dissoci
insulin
oligom
investig
microcalorimetri
expect
dissoci
insulin
oligom
increas
upon
addit
cd
dissoci
clearli
relat
interact
cd
protein
side
chain
inde
dissoci
insulin
oligom
endotherm
without
cd
wherea
presenc
dissoci
less
endotherm
due
exotherm
bind
expos
group
insulin
monom
dissoci
therefor
facilit
oligom
dissoci
contrast
dissoci
observ
endotherm
presenc
although
oligom
dissoci
induc
author
suggest
bind
endotherm
entropi
driven
nativ
modifi
cd
abl
complex
amino
acid
constitut
peptid
protein
molecul
use
separ
capillari
zone
electrophoresi
context
rathor
report
electrophoret
medium
aqueou
buffer
solut
ph
enhanc
separ
capillari
zone
electrophoresi
raw
fusedsilica
standard
protein
cytochrom
c
lysozym
ribonucleas
obtain
result
prove
separ
peptid
protein
enhanc
ad
cd
electrophoret
medium
unfortun
certain
cd
use
select
enhanc
inde
contrast
addit
effect
separ
mention
protein
peptid
group
yamamoto
studi
effect
thermal
stabil
aqueou
buffer
solut
chicken
egg
white
lysozym
circular
dichroism
fluoresc
spectroscopi
thermal
stabil
significantli
lower
presenc
wherea
opposit
true
note
thermal
stabil
reduct
import
base
fluoresc
spectroscopi
author
suggest
cd
includ
side
chain
tryptophan
trp
residu
lysozym
within
intern
caviti
diminish
hydrophob
hydrophob
core
lysozym
consequ
lower
thermal
stabil
scheme
addit
cd
molecul
persist
bind
side
chain
trp
residu
retard
renatur
lysozym
propos
mechan
conform
chang
egg
white
lysozym
temperatur
elev
presenc
modifi
cd
find
describ
presum
effect
cd
directli
link
abil
complex
trp
behavior
relat
caviti
size
bind
constant
alway
weaker
modifi
function
see
discuss
h
nmr
spectroscop
studi
reveal
h
nmr
signal
correspond
trp
residu
shift
upon
addit
due
encapsul
tryptophan
residu
caviti
addit
h
nmr
signal
cystein
isoleucin
also
influenc
consider
extent
addit
allow
conclus
hydrophob
amino
acid
residu
also
includ
cd
result
highli
compat
import
thermal
stabil
reduct
observ
presenc
therefor
interact
cd
protein
complic
due
presenc
mani
bind
site
thaumatin
refer
famili
protein
present
sweet
katemf
fruit
thaumatococcu
daniellii
bennett
endem
west
africa
use
worldwid
human
nutrit
pharmacolog
sweeten
flavor
enhanc
mask
bitter
time
sweeter
sucros
thaumatin
shown
bind
gproteincoupl
receptor
gpcr
transmembran
protein
respons
signal
transduct
therefor
interact
cd
thaumatin
could
use
modifi
interact
thaumatin
gpcr
modifi
sweettast
profil
context
thordarson
et
al
studi
interact
thaumatin
nmr
experi
reveal
bind
aromat
residu
thaumatin
bind
constant
activ
bind
site
thaumatin
protein
known
author
synthes
heptapeptid
lysthrglyaspargglyph
mimic
bind
site
thaumatin
result
show
bind
ctermin
solvent
access
phenylalanin
residu
bind
constant
may
interact
activ
bind
site
thaumatin
regul
interact
thaumatin
gpcr
probabl
possibl
varca
et
al
publish
possibl
applic
formul
proteinlik
structur
enzym
peptid
amino
acid
pharmaceut
applic
author
highlight
format
cyclodextrinprotein
supramolecular
complex
use
improv
stabil
howev
intrins
characterist
guest
protein
also
modifi
addit
exceedingli
clear
throughout
paragraph
peptid
protein
moder
bind
constant
cd
compar
lipid
intern
union
pure
appli
chemistri
iupac
defin
carbohydr
class
organ
compound
contain
carbonyl
group
aldehyd
keton
least
two
hydroxi
residu
oh
noteworthi
substanc
deriv
monosaccharid
reduct
carbonyl
group
oxid
least
one
function
group
end
chain
carboxyl
acid
replac
one
hydroxi
group
hydrogen
atom
amin
thiol
similar
group
also
call
carbohydr
carbohydr
protein
lipid
essenti
constitu
live
organ
key
biolog
intermedi
energi
storag
autotroph
plant
sugar
convert
starch
wherea
heterotroph
organ
anim
store
glycogen
howev
polysaccharid
serv
also
structur
compon
cellulos
plant
chitin
arthropod
moreov
saccharid
deriv
play
key
role
immun
system
fertil
blood
clot
inform
transfer
etc
instanc
monosaccharid
ribos
form
backbon
genet
molecul
rna
see
also
import
compon
coenzym
atp
fad
nad
aoyama
et
al
report
select
complex
pentos
hexos
base
competit
inhibit
bind
follow
fluoresc
measur
bind
constant
estim
obtain
result
reveal
dribos
dand
larabinos
dxylos
dlyxos
methyl
complex
bind
constant
contrast
aldohexos
deriv
dglucos
dgalactos
dmannos
dand
lfucos
methyl
complex
bind
constant
bind
constant
directli
correl
hydrophob
sugar
nevertheless
hbond
hydroxi
group
bound
sugar
oh
group
also
extrem
import
determin
structur
select
complex
noteworthi
sever
public
studi
interact
dglucos
nativ
cd
instanc
hirsh
cowork
estim
bind
constant
dglucos
respect
blood
glucos
meter
contrast
hacket
et
al
determin
bind
constant
dglucos
fluorimetr
competit
titrat
result
obtain
hacket
et
al
closer
valu
publish
aoyama
cowork
addit
quit
logic
dglucos
interact
weakli
nativ
cd
due
size
hydrophil
properti
howev
conflict
result
turner
propos
use
kinet
measur
determin
associ
constant
sever
sugar
new
method
publish
bind
constant
obtain
three
group
report
tabl
b
taken
c
taken
valu
rel
close
bind
constant
increas
order
dgalactos
dglucos
dmannos
darabinos
dxylos
dribos
magnitud
consist
order
magnitud
sugar
hydrophob
scale
determin
janado
yano
scheme
hydrophob
scale
corrobor
wei
pohoril
hexos
seri
therefor
even
literatur
valu
bind
constant
obtain
differ
method
especi
selfconsist
clear
select
recogn
pentos
contrast
hexos
howev
bind
constant
remain
small
see
tabl
base
result
interact
cd
carbohydr
aqueou
solut
complet
neglect
similar
conclus
made
paal
szeijtli
nucleic
acid
macromolecul
monom
nucleotid
nucleotid
three
compon
sugar
phosphat
group
nitrogen
base
nucleotid
join
phosphodiest
bond
two
type
nucleic
acid
accord
sugar
deoxyribos
ribos
deoxyribonucl
acid
dna
ribonucl
acid
rna
nucleic
acid
function
encod
transmit
express
genet
inform
nucleic
acid
allow
synthesi
protein
modif
result
numer
consequ
earlier
mention
cd
use
numer
commerci
applic
therefor
investig
nucleic
acid
interact
eg
dna
rna
variou
type
cd
import
evalu
possibl
intracellular
effect
cd
interact
nativ
cd
nucleic
acid
still
subject
intens
discuss
along
past
year
instanc
result
found
literatur
contradictori
inde
work
komiyama
tee
spi
et
al
suggest
interact
dna
caviti
molecul
small
accommod
dna
base
pair
result
support
work
hoffmann
bock
examin
complex
format
differ
cd
nucleotid
contrast
recent
work
jaffer
et
al
found
form
hbond
dna
base
pair
flip
spontan
room
temperatur
lead
dna
denatur
consequ
exclus
inclus
complex
achiev
respect
nevertheless
noteworthi
complex
form
ribos
phosphat
group
nucleotid
exert
also
stabil
effect
establish
hbond
outer
rim
cd
molecul
interestingli
extent
complex
depend
significantli
base
composit
doubleor
triplehel
structur
contrast
nativ
cd
cation
cd
known
interact
strongli
dna
consequ
cd
use
complex
dna
encapsul
liposom
potenti
gene
therapi
applic
howev
formul
use
obtain
nonvir
vector
sinc
anthrylamin
potent
dnaintercal
properti
ikeda
et
al
attach
anthrylamin
obtain
anthryl
alkylamino
use
chemic
switch
dna
intercal
howev
anthryl
residu
lock
cd
caviti
intercal
dna
possibl
aqueou
solut
upon
addit
ligand
tightli
bound
cd
caviti
eg
host
molecul
releas
anthryl
unit
lead
strong
intercal
doublestrand
dna
molecul
lead
structur
distort
scheme
behavior
clearli
establish
h
nmr
spectroscopi
shift
broaden
anthryl
signal
presenc
guest
concept
could
use
nucleic
acid
reaction
medicin
biotechnolog
import
new
drug
deliveri
system
unfortun
bind
constant
cd
nucleic
acid
remain
rel
modest
close
observ
peptid
protein
see
mention
earlier
cd
abl
complex
biomolecul
unfortun
strength
behavior
depend
molecular
structur
instanc
bind
constant
increas
order
carbohydr
nucleic
acid
protein
lipid
consequ
major
biolog
investig
cd
involv
abil
extract
lipid
cholesterol
phospholipid
plasma
membran
expect
capac
use
numer
applic
sake
clariti
typic
applic
cdcellular
interact
report
previous
mention
cd
abl
interact
complex
cholesterol
other
lipid
great
number
public
deal
topic
consequ
phenomenon
eg
hemolysi
cytotox
see
section
sinc
nineti
known
high
affin
vitro
sterol
compar
lipid
consequ
molecul
use
manipul
cellular
cholesterol
content
modifi
cholesterol
metabol
stimul
remov
cholesterol
varieti
cell
cultur
note
cholesterol
extract
cd
time
dose
depend
addit
exposur
cell
modifi
mm
concentr
rang
result
high
rate
cell
cholesterol
efflux
typic
exampl
present
section
cd
use
demonstr
presenc
differ
kinet
pool
cholesterol
within
cell
model
inde
cd
use
recent
monitor
movement
cholesterol
monolay
liposom
bilay
instanc
typic
paper
publish
leventi
silviu
order
character
cd
capac
bind
cholesterol
author
examin
catalyt
transfer
cholesterol
liposom
compos
phosphatidylcholin
sopc
sopccholesterol
steadi
state
condit
neglig
fraction
sterol
bound
cd
ie
presenc
submillimolar
concentr
acceler
consider
rate
cholesterol
transfer
lipid
vesicl
respect
improv
clearli
greater
transfer
phospholipid
opposit
true
kinet
cdmediat
cholesterol
transfer
indic
transbilay
flipflop
cholesterol
rapid
halftim
min
case
author
report
rel
affin
cholesterol
differ
phospholipid
expect
strong
variat
cholesterol
affin
observ
depend
degre
chain
unsatur
headgroup
structur
transfer
reveal
cholesterol
interact
markedli
higher
affin
sphingolipid
membran
phospholipid
extens
work
huang
london
highlight
possibl
prepar
asymmetr
vesicl
exchang
membran
lipid
differ
vesicl
select
inclus
phospholipid
andor
cholesterol
cd
caviti
moreov
cd
also
use
monitor
intracellular
movement
cholesterol
tissu
cultur
cell
cholesterol
extract
cd
occur
usual
high
rate
cd
use
demonstr
presenc
differ
kinet
pool
cholesterol
within
cell
unfortun
paper
studi
dynam
process
cell
instanc
kinet
cholesterol
efflux
examin
differ
cell
line
fibroblast
human
erythrocyt
rat
cerebellar
neuron
differenti
human
neuron
astrocyt
etc
result
indic
cd
induc
cholesterol
sphingolipid
phospholipid
extract
cytoplasm
membran
typic
rang
origin
amount
castagn
cowork
studi
cholesterol
extract
nativ
modifi
endotheli
cell
huvec
measur
residu
cholesterol
content
cell
reveal
cholesterol
extract
dose
depend
relationship
expect
correl
obtain
cytotox
affin
cholesterol
affin
cd
cholesterol
classifi
order
similar
result
obtain
biolog
membran
anoth
typic
exampl
publish
steck
et
al
author
investig
cholesterol
movement
creat
treatment
human
erythrocyt
result
show
rate
efflux
approxim
three
order
magnitud
higher
cholesterol
transfer
cell
synthet
vesicl
therefor
effici
extract
larg
amount
membran
cholesterol
high
rate
cd
also
catalyz
exchang
cholesterol
serum
lipoprotein
cell
atherosclerosi
vascular
diseas
asvd
caus
inflamm
arteri
wall
caus
increas
cholesterol
blood
level
accumul
cholesterol
crystal
subendotheli
space
lead
arteriosclerot
plaqu
format
noteworthi
cholesterol
repres
maximum
total
mass
plaqu
consequ
elast
arteri
wall
reduc
puls
pressur
modifi
blood
clot
form
scheme
cardiovascular
diseas
current
lead
caus
death
worldwid
plasma
level
cholesterol
associ
cardiovascular
morbid
mortal
use
cd
solubil
remov
cholesterol
plaqu
promis
combat
deadli
condit
noteworthi
high
concentr
modifi
result
rate
cell
cholesterol
efflux
far
excess
achiev
physiolog
cholesterol
acceptor
highdens
lipoprotein
hdl
inde
plasma
level
hdl
invers
associ
cardiovascular
morbid
mortal
lipoprotein
respons
transport
cholesterol
liver
elimin
opposit
hold
lowdens
lipoprotein
ldl
function
transport
cholesterol
free
esterifi
blood
bodi
bring
cell
hdl
particl
also
reduc
macrophag
accumul
thu
help
prevent
even
regress
atherosclerosi
alter
cellular
cholesterol
regul
name
revers
cholesterol
transport
rct
could
use
block
atheroprogress
associ
differ
sever
degre
atherosclerosi
pathogenesi
pioneer
work
iri
et
al
becam
clear
cd
use
prevent
atherosclerosi
critic
step
format
atherosclerosi
plaqu
recruit
monocyt
type
white
blood
cell
differenti
macrophag
ingest
ldl
murphi
et
al
propos
prevent
activationexpress
monocyt
adhes
cell
adhes
molecul
requir
therefor
author
report
cholesterol
complex
inhibit
activ
cholesterol
content
lipid
raft
diminish
treatment
cholesterol
acceptor
author
propos
cholesterol
efflux
serum
monocyt
main
mechan
probabl
effect
mean
inhibit
develop
atherosclerot
plaqu
montecucco
et
al
report
antiatherosclerot
action
kleptos
crysmeb
mixtur
methyl
domin
atherosclerot
mous
model
expect
interf
action
cholesterol
metabol
posit
impact
atherogenesi
lipid
profil
atherosclerot
plaqu
inflamm
addit
reduc
triglycerid
serum
level
cd
reduc
cholesterol
accumul
atherosclerot
plaqu
modif
hdlcholesterol
level
noteworthi
hdl
apolipoprotein
ai
apoai
caus
dosedepend
reduct
activ
ie
antiinflammatori
effect
monocyt
interact
sever
receptor
hdl
apoai
respect
howev
process
lead
aberr
accumul
cholesterol
arteri
wall
form
atherosclerot
plaqu
complex
thu
alter
rct
well
express
function
transport
srbi
involv
process
could
use
fight
atherosclerosi
pathogenesi
point
coisn
cowork
rct
alter
poorli
studi
arteri
endotheli
cell
smooth
muscl
cell
level
consequ
author
investig
effect
differ
methyl
rct
arteri
endotheli
smooth
muscl
cell
note
two
cell
type
express
basal
level
srbi
wherea
sole
found
arteri
endotheli
cell
author
highlight
correl
percentag
cholesterol
extract
methyl
degre
cd
effect
clearli
independ
membran
composit
express
level
well
cholesterol
efflux
apoai
hdl
reduc
due
cholesterolmethyl
interact
consequ
cellular
cholesterol
involv
atherosclerot
lesion
lower
express
transport
involv
rct
clearli
modul
zimmer
et
al
publish
effect
order
reduc
atherosclerot
plaqu
use
dissolv
cholesterol
crystal
respons
complex
inflammatori
respons
excret
bodi
urin
mice
fed
cholesterolrich
diet
week
order
promot
fatti
plaqu
blood
vessel
ie
obtain
atherosclerot
mice
week
start
inject
inject
week
remain
four
week
author
observ
plaqu
reduct
atherosclerot
mice
consum
compar
plaqu
blood
vessel
untreat
anim
reduct
mechanist
point
view
research
suspect
cd
boost
activ
macrophag
enabl
attack
excess
cholesterol
without
caus
inflamm
inde
cd
increas
liver
x
receptor
lxr
involv
antiatherosclerot
antiinflammatori
effect
well
rct
improv
moreov
also
use
reduc
ldl
cholesterol
alter
plasma
fatti
acid
profil
doubl
blind
placebocontrol
clinic
trial
publish
effect
oral
week
daili
gram
dose
allow
reduc
fast
plasma
glucos
level
p
insulin
index
p
healthi
men
women
addit
ldl
cholesterol
level
reduc
p
compar
placebo
cd
well
toler
seriou
advers
event
report
patient
treat
report
side
effect
minor
gastrointestin
symptom
placebo
consequ
use
safe
well
toler
show
reduct
ldl
cholesterol
improv
fast
plasma
glucos
abil
cd
chang
contract
arteri
smooth
muscl
indic
cellular
cholesterol
level
extrem
import
factor
cardiovascular
system
continu
research
front
could
potenti
lead
major
advanc
fight
heart
diseas
like
bodi
system
cell
nervou
system
also
suscept
cholesterol
extract
mediat
cd
present
section
sake
clariti
potenti
applic
cd
fight
alzheim
niemannpick
type
c
diseas
ad
npc
respect
report
ad
chronic
neurodegen
diseas
repres
case
dementia
diseas
character
format
amyloid
plaqu
brain
often
associ
cerebr
accumul
amyloidogen
peptid
product
mediat
two
neuron
enzym
inhibit
methyl
via
cholesterol
deplet
addit
yao
cowork
demonstr
reduc
cell
membran
cholesterol
accumul
cell
overexpress
swedish
mutant
app
moreov
cd
dramat
lower
level
cell
well
amyloid
plaqu
deposit
reduct
app
protein
cleavag
upregul
gene
express
involv
cholesterol
transport
cell
model
cd
also
improv
clearanc
mechan
cd
also
exert
signific
benefici
effect
npc
diseas
share
neuropatholog
featur
ad
disord
character
abnorm
endosomallysosom
storag
diseas
associ
genet
mutat
gene
code
protein
involv
intracellular
cholesterol
transport
consequ
function
impair
protein
caus
progress
neurodegener
well
liver
lung
diseas
two
protein
act
tandem
promot
export
cholesterol
endosomeslysosom
cd
bypass
function
trap
transport
membranestor
cholesterol
endosomeslysosom
abil
cd
sequest
transport
cholesterol
could
potenti
lead
major
advanc
abil
fight
neurodegen
diseas
cholesterol
level
plasma
membran
extrem
import
mani
part
viral
infect
process
entri
releas
virion
host
cell
well
transport
variou
viral
protein
cd
clear
antivir
activ
influenza
viru
human
immunodefici
viru
murin
corona
viru
polioviru
human
cell
leukemia
viru
newcastl
viru
varicellazost
duck
human
hepat
b
viru
bluetongu
viru
etc
case
abil
cd
decreas
membran
cholesterol
propos
antivir
mechan
nevertheless
biolog
effect
cd
classifi
accord
role
imped
viral
entri
host
cell
ii
decreas
rel
infect
virion
iii
decreas
observ
viral
titer
iv
disrupt
surfac
transport
influenza
viru
hemagglutinin
typic
exampl
cd
effect
pathogen
sever
virus
report
hiv
wide
studi
viru
term
effect
cd
instanc
sulfat
cd
abl
inhibit
hiv
infect
leydet
et
al
demonstr
antihiv
anticytomegaloviru
activ
sever
charg
cd
deriv
liao
et
al
report
exhibit
also
antihiv
activ
base
cholesterol
deplet
howev
mechan
yet
determin
sinc
membran
cholesterol
lipid
raftbas
receptor
strictli
requir
infect
hiv
entri
cd
excel
candid
use
chemic
barrier
aid
prophylaxi
anoth
common
viral
diseas
caus
herp
simplex
viru
hsv
lead
sever
distinct
medic
disord
includ
orofaci
genit
herp
enceph
context
antihsv
properti
nativ
cd
estim
antivir
properti
clearli
depend
caviti
size
exhibit
signific
antiherpet
activ
similar
condit
reduc
cellfre
cellassoci
viru
effect
acyclovir
ie
antiherpet
drug
inde
result
reveal
almost
complet
protect
vero
cell
acyclovirsensit
acyclovirresist
strain
hsv
abil
imped
viru
replic
propos
antivir
mechan
potenti
occurr
synergist
effect
present
special
case
may
occur
one
substanc
increas
activ
anoth
current
gap
knowledg
circumst
effect
may
occur
eg
mixtur
composit
contact
time
speci
exposur
concentr
often
hamper
predict
approach
howev
sinc
cd
abl
extract
cholesterol
lipid
viral
membran
like
combin
virucid
antivir
drug
act
target
result
synergist
effect
base
assumpt
group
studi
combin
dindecyldimethylammonium
chlorid
dic
cl
wide
use
cation
surfact
intrins
virucid
activ
nativ
cd
mark
synerg
observ
lipidcontain
deoxyribonucl
ribonucl
acid
virus
respiratori
syncyti
viru
rsv
vaccinia
virus
vacv
inde
notic
reduct
dic
cl
concentr
ie
activ
virucid
obtain
rsv
vacv
respect
case
submillimolar
dic
cl
concentr
requir
obtain
reduct
equival
reduct
viral
titer
therefor
dilut
solut
free
cd
dic
speci
prevail
due
le
principl
moreov
micel
equilibrium
relev
virucid
activ
clearli
obtain
premicellar
region
thu
propos
mechan
synergi
base
abil
cd
extract
rapidli
cholesterol
viral
envelop
inde
catalyz
rapid
exchang
cholesterol
viral
envelop
aqueou
solut
sequestr
cholesterol
bulk
phase
facilit
dic
insert
within
lipid
envelop
lead
viru
inactiv
scheme
mean
acceler
rate
cholesterol
extract
larger
factor
propos
mechan
highli
compat
result
leventi
silviu
see
result
demonstr
clear
effect
cd
viabil
envelop
virus
provid
evid
potenti
use
order
improv
effici
common
antivir
medic
cholesterol
extract
gener
limit
viral
infect
whole
rang
studi
shown
presenc
cd
imped
entri
bacteria
fungi
parasit
host
cell
effect
demonstr
plasmodium
speci
campylobact
jejuni
leishmania
donovani
etc
behavior
explain
vital
role
lipid
raft
bind
entri
pathogen
host
cell
therefor
synergist
effect
also
alon
behavior
attribut
interact
lipid
membran
compon
relev
exampl
found
review
macaev
et
al
review
propos
overview
current
potenti
applic
cd
throughout
interact
endogen
substanc
origin
within
organ
tissu
cell
major
applic
base
capac
cd
withdraw
cholesterol
plasma
membran
behavior
present
sever
applic
cholesterol
manipul
control
viral
bacteri
infect
treatment
alzheim
heart
diseas
etc
moreov
cd
present
viabl
basi
context
green
pharmaci
medicin
last
decad
concept
ecofriendli
pharmaci
emerg
respons
kreisberg
question
clinician
reduc
environment
impact
medic
cours
answer
base
similar
principl
green
chemistri
initi
develop
anasta
warner
principl
cover
variou
concept
use
biosourc
ingredi
ii
use
green
concept
product
chemic
synthesi
process
life
cycl
engin
packag
wast
manag
iii
reduct
neg
impact
medic
transport
iv
reduct
healthcar
environment
footprint
v
reduct
use
pharmaceut
vi
improv
ultim
drug
dispos
use
takeback
program
cd
biosourc
compound
low
toxic
danger
easili
biodegrad
use
obtain
sustain
drug
formul
cd
act
activ
green
ingredi
excipi
noteworthi
cd
use
alon
combin
common
petrosourc
medic
synergist
effect
two
molecul
obtain
signific
amount
drug
replac
ecoand
biocompat
cd
whilst
maintain
biolog
activ
particularli
interest
solv
least
partial
neg
impact
pharmaceut
formul
environ
consequ
context
greener
pharmaci
cd
contribut
without
doubt
preserv
planet
come
year
